How Is Nanotechnology Being Used in Clinical Trials for Cancer?
Numerous clinical trials are underway to evaluate the safety and efficacy of nanotechnology-based cancer therapies. For instance, trials are investigating the use of liposomal formulations of chemotherapeutic agents to improve their delivery and reduce side effects. Other trials are exploring the potential of siRNA-loaded nanoparticles to silence specific genes involved in cancer progression. These trials are crucial for translating nanotechnology research from the lab to clinical practice.
